Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry F Chambers

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
Research Square|May 19, 2025
Spatial clusters of dominant lineages of uropathogenic Escherichia coli in a community dwelling patient populationCheyenne Belmont, Pushkar Inamdar, Salma Shariff-Marco, et al.
American Journal of Infection Control|December 2, 2004
Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococciLisa G Winston, Edwin D Charlebois, Szekim Pang, et al.
Emerging Infectious Diseases|June 8, 2007
Intermediate vancomycin susceptibility in a community-associated MRSA cloneChristopher J Graber, Margaret K Wong, Heather A Carleton, et al.
Journal of Clinical Microbiology|November 27, 2009
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolidRodrigo E Mendes, Helio S Sader, Lalitagauri M Deshpande, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
Ability of Bicarbonate Supplementation To Sensitize Selected Methicillin-Resistant <i>Staphylococcus aureus</i> Strains to β-Lactam Antibiotics in an <i>Ex Vivo</i> Simulated Endocardial Vegetation ModelWarren E Rose, Ana M Bienvenida, Yan Q Xiong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2005
Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay areaJose M Eguia, Catherine Liu, Matthew Moore, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2024
NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA)Selvi C Ersoy, Sabrina L Madrigal, Richard A Proctor, et al.
Plos One|February 19, 2016
Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of ResistanceAlexander L Greninger, Som S Chatterjee, Liana C Chan, et al.
Open Forum Infectious Diseases|December 20, 2017
Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and AbscessAsha C Bowen, Jonathan R Carapetis, Bart J Currie, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus BacteremiaSanjiv M Baxi, Angelo Clemenzi-Allen, Alice Gahbauer, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
Research Square|May 19, 2025
Spatial clusters of dominant lineages of uropathogenic Escherichia coli in a community dwelling patient populationCheyenne Belmont, Pushkar Inamdar, Salma Shariff-Marco, et al.
American Journal of Infection Control|December 2, 2004
Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococciLisa G Winston, Edwin D Charlebois, Szekim Pang, et al.
Emerging Infectious Diseases|June 8, 2007
Intermediate vancomycin susceptibility in a community-associated MRSA cloneChristopher J Graber, Margaret K Wong, Heather A Carleton, et al.
Journal of Clinical Microbiology|November 27, 2009
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolidRodrigo E Mendes, Helio S Sader, Lalitagauri M Deshpande, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
Ability of Bicarbonate Supplementation To Sensitize Selected Methicillin-Resistant <i>Staphylococcus aureus</i> Strains to β-Lactam Antibiotics in an <i>Ex Vivo</i> Simulated Endocardial Vegetation ModelWarren E Rose, Ana M Bienvenida, Yan Q Xiong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2005
Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay areaJose M Eguia, Catherine Liu, Matthew Moore, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2024
NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA)Selvi C Ersoy, Sabrina L Madrigal, Richard A Proctor, et al.
Plos One|February 19, 2016
Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of ResistanceAlexander L Greninger, Som S Chatterjee, Liana C Chan, et al.
Open Forum Infectious Diseases|December 20, 2017
Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and AbscessAsha C Bowen, Jonathan R Carapetis, Bart J Currie, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2016
Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus BacteremiaSanjiv M Baxi, Angelo Clemenzi-Allen, Alice Gahbauer, et al.
Pageof 19